company background image
MEDP logo

Medpace Holdings NasdaqGS:MEDP Stock Report

Last Price

US$362.79

Market Cap

US$11.3b

7D

13.5%

1Y

31.8%

Updated

10 Nov, 2024

Data

Company Financials +

Medpace Holdings, Inc.

NasdaqGS:MEDP Stock Report

Market Cap: US$11.3b

MEDP Stock Overview

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

MEDP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance6/6
Financial Health5/6
Dividends0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Medpace Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medpace Holdings
Historical stock prices
Current Share PriceUS$362.79
52 Week HighUS$459.77
52 Week LowUS$268.80
Beta1.37
11 Month Change4.28%
3 Month Change-3.47%
1 Year Change31.75%
33 Year Change63.51%
5 Year Change399.02%
Change since IPO1,193.83%

Recent News & Updates

Medpace: Buy The Short-Term Pain For Long-Term Gains

Oct 26

Why Medpace Holdings Is A 'Better Mousetrap'

Oct 16

Recent updates

Medpace: Buy The Short-Term Pain For Long-Term Gains

Oct 26

Why Medpace Holdings Is A 'Better Mousetrap'

Oct 16

Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors

Sep 19
Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors

Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?

Sep 02
Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?

Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity

Aug 20

Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem

Jul 31
Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem

Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jul 25
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E

Jun 18
What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E

Medpace: Clear Winner If China Blockade Succeeds

Jun 04

A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

May 22
A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?

Apr 12
Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?

Medpace: Exceptional Performance, Almost Fully Priced In

Mar 11

Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors

Feb 18
Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors

Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?

Feb 09
Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?

A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

Jan 25
A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?

Jan 10
Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?

Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price

Dec 26
Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price

Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?

Nov 08
Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?

Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate

Oct 23
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate

If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity

Oct 10
If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity

Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?

Aug 27
Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?

Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?

Jul 31
Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?

A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

Jul 18
A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today

Jul 04
Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today

Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?

May 25
Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?

Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?

Apr 27
Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?

An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued

Apr 12
An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued

We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease

Mar 27
We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease

Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?

Feb 14
Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?

What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?

Jan 16
What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?

Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate

Jan 03
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate

Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today

Dec 20
Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today

Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet

Nov 16
Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet

Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%

Nov 03
Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%

Shareholder Returns

MEDPUS Life SciencesUS Market
7D13.5%1.1%5.1%
1Y31.8%19.6%36.3%

Return vs Industry: MEDP exceeded the US Life Sciences industry which returned 19.6% over the past year.

Return vs Market: MEDP underperformed the US Market which returned 36.3% over the past year.

Price Volatility

Is MEDP's price volatile compared to industry and market?
MEDP volatility
MEDP Average Weekly Movement5.9%
Life Sciences Industry Average Movement7.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market3.0%

Stable Share Price: MEDP has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: MEDP's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19925,900August Troendlewww.medpace.com

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.

Medpace Holdings, Inc. Fundamentals Summary

How do Medpace Holdings's earnings and revenue compare to its market cap?
MEDP fundamental statistics
Market capUS$11.25b
Earnings (TTM)US$365.57m
Revenue (TTM)US$2.07b

30.8x

P/E Ratio

5.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEDP income statement (TTM)
RevenueUS$2.07b
Cost of RevenueUS$678.86m
Gross ProfitUS$1.39b
Other ExpensesUS$1.03b
EarningsUS$365.57m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.79
Gross Margin67.22%
Net Profit Margin17.65%
Debt/Equity Ratio0%

How did MEDP perform over the long term?

See historical performance and comparison